Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease

Clinical trial NCT02633020 · COMPLETED

Trial details

NCT number: NCT02633020
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type II Refractory Celiac Disease (RCD-II)In-situ Small Bowel T-cell Lymphoma

Start date: 2016-04-13
Primary completion: 2017-04-11
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.